Both in Biotechnology
Cullinan Therapeutics vs Sana Biotechnology
Over the past year CGEM returned +59.2% and SANA returned −43.4%; their daily moves had a correlation of 0.31.
CGEM +59.2% SANA −43.4%Growth of $1, one year, split-adjusted
| Metric | CGEM | SANA |
|---|---|---|
| Price | $12.44 | $2.59 |
| Market cap | $800.3M | $773.8M |
| Today | −21.05% | +5.94% |
| 1 month | −23.5% | −6.0% |
| 6 months | −17.0% | −29.0% |
| Year to date | +20.1% | −36.5% |
| 1 year | +59.2% | −43.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $334.5M | $160.5M |
| Dividend yield | — | — |
| Volatility (60d) | 88.1% | 72.9% |
| Short % of float | 14.3% | 22.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).